![Alfredo Zurlo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alfredo Zurlo
Keine laufenden Positionen mehr
Karriereverlauf von Alfredo Zurlo
Ehemalige bekannte Positionen von Alfredo Zurlo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MOLOGEN AG | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2013 | 31.03.2016 |
SCANDION ONCOLOGY A/S | Technik-/Wissenschafts-/F&E-Leiter | 11.05.2022 | - |
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | 01.05.2016 | - |
Ausbildung von Alfredo Zurlo
The American University of Rome | Doctorate Degree |
Statistik
International
Deutschland | 3 |
Italien | 2 |
Dänemark | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MOLOGEN AG | Commercial Services |
SCANDION ONCOLOGY A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Health Technology |
- Börse
- Insiders
- Alfredo Zurlo
- Erfahrung